ArticleScientific reports2021

Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX.

Hye Eun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.